{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,14]],"date-time":"2026-01-14T05:17:37Z","timestamp":1768367857221,"version":"3.49.0"},"reference-count":15,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2026,1,13]]},"DOI":"10.7759\/cureus.101467","type":"journal-article","created":{"date-parts":[[2026,1,13]],"date-time":"2026-01-13T23:22:08Z","timestamp":1768346528000},"source":"Crossref","is-referenced-by-count":0,"title":["Prolonged Cholestatic Hepatitis A With Transient Epstein-Barr Virus IgM Reactivity and Marked Hyperferritinemia in an HFE H63D Heterozygote"],"prefix":"10.7759","author":[{"given":"Sara R","family":"Silva","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Filipe","family":"Dias","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Cl\u00e1udia","family":"Ribeiro","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"F\u00e1tima","family":"Augusto","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"C\u00e1tia","family":"Albino","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.3346\/jkms.2014.29.2.248","article-title":"Clinical characteristics and outcomes of acute hepatitis a in Korea: a nationwide multicenter study","volume":"29","author":"Kwon SY","year":"2014","unstructured":"Kwon SY, Park SH, Yeon JE, et al.. Clinical characteristics and outcomes of acute hepatitis a in Korea: a nationwide multicenter study. J Korean Med Sci. 2014, 29:248-53. 10.3346\/jkms.2014.29.2.248","journal-title":"J Korean Med Sci"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.7759\/cureus.38511","article-title":"Prolonged cholestasis following acute hepatitis A infection: case report and a review of literature","volume":"15","author":"Alebaji MB","year":"2023","unstructured":"Alebaji MB, Mehair AS, Shahrour OI, Elkhatib FA, Alkaabi EH, Alkuwaiti NS. Prolonged cholestasis following acute hepatitis A infection: case report and a review of literature. Cureus. 2023, 15:e38511. 10.7759\/cureus.38511","journal-title":"Cureus"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.3390\/v13050861","article-title":"Mechanisms of hepatocellular injury in hepatitis A","volume":"13","author":"Wang M","year":"2021","unstructured":"Wang M, Feng Z. Mechanisms of hepatocellular injury in hepatitis A. Viruses. 2021, 13:861. 10.3390\/v13050861","journal-title":"Viruses"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1016\/j.jceh.2025.102557","article-title":"Therapeutic options for the management of the cholestatic phase of viral hepatitis A and E\u2014a systematic review","volume":"15","author":"Giri S","year":"2025","unstructured":"Giri S, Khatana G, Gore P, Praharaj DL, Kulkarni AV, Anand AC. Therapeutic options for the management of the cholestatic phase of viral hepatitis A and E\u2014a systematic review. J Clin Exp Hepatol. 2025, 15:102557. 10.1016\/j.jceh.2025.102557","journal-title":"J Clin Exp Hepatol"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.14309\/ajg.0000000000000315","article-title":"ACG clinical guideline: hereditary hemochromatosis","volume":"114","author":"Kowdley KV","year":"2019","unstructured":"Kowdley KV, Brown KE, Ahn J, Sundaram V. ACG clinical guideline: hereditary hemochromatosis. Am J Gastroenterol. 2019, 114:1202-18. 10.14309\/ajg.0000000000000315","journal-title":"Am J Gastroenterol"},{"key":"ref6","article-title":"Infectious mononucleosis: rapid evidence review","volume":"107","author":"Sylvester JE","year":"2023","unstructured":"Sylvester JE, Buchanan BK, Silva TW. Infectious mononucleosis: rapid evidence review. Am Fam Physician. 2023, 107:71-78.","journal-title":"Am Fam Physician"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhep.2022.03.033","article-title":"EASL Clinical Practice Guidelines on haemochromatosis","volume":"77","author":"European Association for the Study of the Liver","year":"2022","unstructured":"European Association for the Study of the Liver. EASL Clinical Practice Guidelines on haemochromatosis. J Hepatol. 2022, 77:479-502. 10.1016\/j.jhep.2022.03.033","journal-title":"J Hepatol"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(23)00287-8","article-title":"Haemochromatosis","volume":"401","author":"Adams PC","year":"2023","unstructured":"Adams PC, Jeffrey G, Ryan J. Haemochromatosis. Lancet. 2023, 401:1811-21. 10.1016\/S0140-6736(23)00287-8","journal-title":"Lancet"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1038\/ajg.2016.517","article-title":"ACG clinical guideline: evaluation of abnormal liver chemistries","volume":"112","author":"Kwo PY","year":"2017","unstructured":"Kwo PY, Cohen SM, Lim JK. ACG clinical guideline: evaluation of abnormal liver chemistries. Am J Gastroenterol. 2017, 112:18-35. 10.1038\/ajg.2016.517","journal-title":"Am J Gastroenterol"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1002\/hep.20169","article-title":"Screening in liver disease: report of an AASLD clinical workshop","volume":"39","author":"Adams PC","year":"2004","unstructured":"Adams PC, Arthur MJ, Boyer TD, et al.. Screening in liver disease: report of an AASLD clinical workshop. Hepatology. 2004, 39:1204-12. 10.1002\/hep.20169","journal-title":"Hepatology"},{"key":"ref11","unstructured":"Acute viral hepatitis (case). (2016). Accessed. December 22, 2025: https:\/\/radiopaedia.org\/cases\/acute-viral-hepatitis."},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1016\/S1665-2681(19)31448-6","article-title":"Prolonged cholestasis triggered by hepatitis A virus infection and variants of the hepatocanalicular phospholipid and bile salt transporters","volume":"11","author":"Krawczyk M","year":"2012","unstructured":"Krawczyk M, Gr\u00fcnhage F, Langhirt M, Bohle RM, Lammert F. Prolonged cholestasis triggered by hepatitis A virus infection and variants of the hepatocanalicular phospholipid and bile salt transporters. Ann Hepatol. 2012, 11:710-4. 10.1016\/S1665-2681(19)31448-6","journal-title":"Ann Hepatol"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.3350\/kjhep.2012.18.1.84","article-title":"Drug rash with eosinophilia and systemic symptoms syndrome following cholestatic hepatitis A: a case report","volume":"18","author":"An J","year":"2012","unstructured":"An J, Lee JH, Lee H, et al.. Drug rash with eosinophilia and systemic symptoms syndrome following cholestatic hepatitis A: a case report. Korean J Hepatol. 2012, 18:84-8. 10.3350\/kjhep.2012.18.1.84","journal-title":"Korean J Hepatol"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1136\/bcr-2020-234430","article-title":"Prolonged cholestasis after acute viral hepatitis: successfully treated with oral steroid","volume":"13","author":"Jayappa M","year":"2020","unstructured":"Jayappa M, Kumar P, Goyal JP. Prolonged cholestasis after acute viral hepatitis: successfully treated with oral steroid. BMJ Case Rep. 2020, 13:e234430. 10.1136\/bcr-2020-234430","journal-title":"BMJ Case Rep"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1093\/omcr\/omz080","article-title":"Two case reports of corticosteroid administration-prolonged and pulsed therapy-in treatment of pruritus in cholestatic hepatitis A patients","volume":"2019","author":"Daghman D","year":"2019","unstructured":"Daghman D, Rez MS, Soltany A, Alsaleh A. Two case reports of corticosteroid administration-prolonged and pulsed therapy-in treatment of pruritus in cholestatic hepatitis A patients. Oxf Med Case Reports. 2019, 2019:omz080. 10.1093\/omcr\/omz080","journal-title":"Oxf Med Case Reports"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/448842-prolonged-cholestatic-hepatitis-a-with-transient-epstein-barr-virus-igm-reactivity-and-marked-hyperferritinemia-in-an-hfe-h63d-heterozygote","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,1,13]],"date-time":"2026-01-13T23:22:11Z","timestamp":1768346531000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/448842-prolonged-cholestatic-hepatitis-a-with-transient-epstein-barr-virus-igm-reactivity-and-marked-hyperferritinemia-in-an-hfe-h63d-heterozygote"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1,13]]},"references-count":15,"URL":"https:\/\/doi.org\/10.7759\/cureus.101467","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2026,1,13]]}}}